Trade AVLN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Avalyn Pharma Inc. (AVLN) is trading at US$31.52, down 5.71% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.7B. Over the past 52 weeks, AVLN has traded between US$24.15 and US$40.17. On Syfe you can trade AVLN with $0 commission and add it to your watchlist.
| Previous close | US$33.43 |
|---|---|
| Market cap | US$1.7B |
| 52-week range | US$24.15 – US$40.17 |
| Volume | 664.78K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Avalyn Pharma Inc.
Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.
Year: 2026
Avalyn Pharma's Q2 Net Loss Widens
Aug 12, 12:30 PM · MT Newswires
--Earnings Flash (AVLN) Avalyn Pharma Posts Q2 Net Loss $28.9M, vs. FactSet Est of $28.6M Loss
Aug 12, 12:12 PM · MT Newswires
--Guggenheim Initiates Avalyn Pharma at Buy With $80 Price Target
May 26, 11:15 AM · MT Newswires
Jefferies Initiates Avalyn Pharma at Buy With $52 Price Target
May 26, 11:14 AM · MT Newswires
--Morgan Stanley Initiates Avalyn Pharma at Overweight With $53 Price Target
May 26, 11:12 AM · MT Newswires
Avalyn Pharma Inc. (AVLN) stock is trading at US$31.52, -5.71% from the previous close of US$33.43.
The market cap for Avalyn Pharma Inc. (AVLN) stock is approximately US$1.7B.
The 52-week high for Avalyn Pharma Inc. (AVLN) stock is US$40.17.
The 52-week low for Avalyn Pharma Inc. (AVLN) stock is US$24.15.
Avalyn Pharma Inc. (AVLN) does not currently pay a dividend.
Stay on top of AVLN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
